Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (01/12/2026) TO PUR COM

0.0159
+0.001913.57%
Volume:35.02K
Turnover:417.62
Market Cap:- -
PE:- -
High:0.0159
Open:0.0141
Low:0.0100
Close:0.0140
Loading ...

Company Profile

Company Name:
CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (01/12/2026) TO PUR COM
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.